GLP-1 Drugs and Obstructive Sleep Apnea: How Weight Loss Medications Improve Breathing During Sleep - News-Medical
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
IntroductionClinical trial evidenceFDA approval and regulatory developmentsCardiometabolic and secondary benefitsFuture directionsReferences
What can treatments targeting weight and metabolism offer people with obstructive sleep apnea, and which questions must clinical trials still answer?
This article is an excerpt. To read the full content, visit the original source. News-Medical
Related articles
Could GLP-1 drugs be anti-aging medications? - CTV News
AtlanticNova ScotiaNew BrunswickPrince Edward Island Newfoundland and LabradorCalgaryLethbridgeKitchenerGuelphNorthern OntarioSudburyNorth BaySault Ste. MarieTimminsOttawaKingstonBrockvillePembrokeReginaYorktonSaskatoonPrince AlbertTorontoWatchWeatherPeelHamiltonDurhamYorkHaltonNiagaraQueen's ParkToronto City HallIn PicturesVancouverVancouver IslandCanadaLocal SpotlightRoyal FamilyPoliticsNanosPower PlayQuestion PeriodFederal Election 2025WorldMideast ConflictRussia-Ukraine WarWatchLatestCaptured on CameraPoliticsLifestyleConsumerHealthExplainedEntertainmentTechnologyDeception DecodedAutosEnvironmentBusinessInflationReal EstateAutos
Polypharmacy of Prescription Medications Increased for US Older Adults - Ophthalmology Advisor
Polypharmacy involving prescription medications affected more than one-third of older adults in 2021 to 2023. HealthDay News — Polypharmacy involving prescription medications affected more than one-third of older adults in 2021 to 2023, according to a research letter published online Sept. 24 in the Journal of the American Medical Association.
0 comments
No comments yet. Be the first to share your thoughts!